# WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)

Study · id `cardio:ct-nct04701684` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04701684](<https://clinicaltrials.gov/study/NCT04701684>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04701684

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 594 participants.

## Technical summary

Registry record NCT04701684. Randomized; no masking; primary purpose diagnostic. Start 2021-06-23 (actual); primary completion 2027-04-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 594 participants (planned count; ClinicalTrials.gov record NCT04701684, source copy `cardio:ctgov-nct04701684-2026-09-29`, retrieved 2026-10-26)
- Started: 2021-06-23 (actual) (ClinicalTrials.gov record NCT04701684, source copy `cardio:ctgov-nct04701684-2026-09-29`, retrieved 2026-10-26)
- Primary completion: 2027-04-01 (anticipated) (ClinicalTrials.gov record NCT04701684, source copy `cardio:ctgov-nct04701684-2026-09-29`, retrieved 2026-10-26)
- Completion: 2027-04-01 (anticipated) (ClinicalTrials.gov record NCT04701684, source copy `cardio:ctgov-nct04701684-2026-09-29`, retrieved 2026-10-26)
- Countries: United States; Argentina; Belgium; Brazil; France; Germany; Netherlands; Romania; Spain; Türkiye (ClinicalTrials.gov record NCT04701684, source copy `cardio:ctgov-nct04701684-2026-09-29`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04701684-2026-09-29`, retrieved 2026-10-26)

## The registry's words

- Brief title: WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
- Condition: Stroke, Acute
- Intervention (Device): Direct to Angio Suite (DTAS) Philips' CBCT triage
- Intervention (Procedure): Conventional CT/MR triage
- Lead sponsor: Philips Clinical & Medical Affairs Global
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Philips Clinical & Medical Affairs Global (`cardio:org-philips-clinical-medical-affairs-global`)

## Provenance

Content hash: cdf0912d8daf8092d27bc07dd30d3deea33a6d3620f8d5328924ebd4c74a61df
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
